BCIP Life Sciences Associates, LP
SEC CIK 1702921 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| XLO | Xilio Therapeutics, Inc. | 10% | 2.78M | $410.1K | — | 1 | 2021-12-08 | 2021-12-08 |
Most active insiders at XLO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Shannon James Samuel | Dir | $43.9K | — |
| 2 | Frankenfield Christopher James | CFO | — | $4,499 |
| 3 | Brennan Kevin M. | SVP, Fin AND ACCOUNTING | — | $1,169 |
| 4 | Luptakova Katarina | Chief MEDICAL Off | — | — |
| 5 | Russo Rene | Pres AND CEO, Dir | — | — |
BCIP Life Sciences Associates, LP made no open-market trades at XLO in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2021-12-10 | 2021-12-08+ | XLO | Xilio Therapeutics, Inc. | BCIP Life Sciences Associates, LP | 10% | P - Purchase | $9.66 | +42.5K | 2.78M | +2% | +$410.1K |
Purchase Sale Sale after option exercise All abbreviations